Doree Sitkoff

Person

Dresher, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Fibronectin based scaffold domain proteins that bind PCSK9
- Patent number 11,858,979
- Issue date Jan 2, 2024
- Bristol-Meyers Squibb Company
- Ray Camphausen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Fibronectin based scaffold domain proteins that bind PCSK9
- Patent number 10,947,297
- Issue date Mar 16, 2021
- Bristol-Myers Squibb Company
- Ray Camphausen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclic ureas as inhibitors of rock
- Patent number 10,123,993
- Issue date Nov 13, 2018
- Bristol-Myers Squibb Company
- Peter W. Glunz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tied-back benzamide derivatives as potent rock inhibitors
- Patent number 10,112,939
- Issue date Oct 30, 2018
- Bristol-Myers Squibb Company
- Zilun Hu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Lactams as inhibitors of rock
- Patent number 10,112,929
- Issue date Oct 30, 2018
- Bristol-Myers Squibb Company
- Peter W. Glunz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fibronectin based scaffold domain proteins that bind PCSK9
- Patent number 9,856,309
- Issue date Jan 2, 2018
- BRISTOL-MYERS SQUIBB COMPANY
- Ray Camphausen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fibronectin based scaffold domain proteins that bind PCSK9
- Patent number 9,234,027
- Issue date Jan 12, 2016
- Bristol-Myers Squibb Company
- Ray Camphausen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fibronectin based scaffold domain proteins that bind to PCSK9
- Patent number 8,420,098
- Issue date Apr 16, 2013
- Bristol-Myers Squibb Company
- Ray Camphausen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
- Patent number 8,119,808
- Issue date Feb 21, 2012
- Bristol-Myers Squibb Company
- Chongqing Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
- Patent number 7,884,113
- Issue date Feb 8, 2011
- Bristol-Myers Squibb Company
- Chongqing Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocycles as cannabinoid-1 receptor modulators
- Patent number 7,858,639
- Issue date Dec 28, 2010
- Bristol-Myers Squibb Company
- Chongqing Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocycles as cannabinoid-1 receptor modulators
- Patent number 7,632,837
- Issue date Dec 15, 2009
- Bristol-Myers Squibb Company
- Chongqing Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azabicyclic heterocycles as cannabinoid receptor modulators
- Patent number 7,378,418
- Issue date May 27, 2008
- Bristol-Myers Squibb Company
- Guixue Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocycles as cannabinoind-1 receptor modulators
- Patent number 7,317,012
- Issue date Jan 8, 2008
- Bristol-Myers Squibb Company
- Chongqing Sun
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND PCSK9
- Publication number 20210277089
- Publication date Sep 9, 2021
- Bristol-Myers Squibb Company
- Ray Camphausen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND PCSK9
- Publication number 20180201665
- Publication date Jul 19, 2018
- Bristol-Myers Squibb Company
- Ray Camphausen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LACTAMS AS INHIBITORS OF ROCK
- Publication number 20180044326
- Publication date Feb 15, 2018
- BRISTOL-MYERS SQUIBB COMAPANY
- Peter W. Glunz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYCLIC UREAS AS INHIBITORS OF ROCK
- Publication number 20180000788
- Publication date Jan 4, 2018
- Bristol-Myers Squibb Company
- Peter W. Glunz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TIED-BACK BENZAMIDE DERIVATIVES AS POTENT ROCK INHIBITORS
- Publication number 20170226105
- Publication date Aug 10, 2017
- BRISTOL-MYERS SQUIBB COMPANY
- Zilun Hu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND PCSK9
- Publication number 20160159883
- Publication date Jun 9, 2016
- Bristol-Myers Squibb Company
- Ray Camphausen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND PCSK9
- Publication number 20130210703
- Publication date Aug 15, 2013
- Bristol-Myers Squibb Company
- Ray Camphausen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO PCSK9
- Publication number 20120094909
- Publication date Apr 19, 2012
- Bristol -Myers Squibb Company
- Ray Camphausen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS
- Publication number 20110104315
- Publication date May 5, 2011
- Bristol -Myers Squibb Company
- Chongqing Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC HETEROCYCLES AS CANNABINOID-1 RECEPTOR MODULATORS
- Publication number 20100048612
- Publication date Feb 25, 2010
- Bristol -Myers Squibb Company
- Chongqing Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS
- Publication number 20080194625
- Publication date Aug 14, 2008
- Bristol -Myers Squibb Company
- Chongqing Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bicyclic heterocycles as cannabinoind-1 receptor modulators
- Publication number 20060287322
- Publication date Dec 21, 2006
- Chongqing Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bicyclic heterocycles as cannabinoid-1 receptor modulators
- Publication number 20060287324
- Publication date Dec 21, 2006
- Chongqing Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Azabicyclic heterocycles as cannabinoid receptor modulators
- Publication number 20050143381
- Publication date Jun 30, 2005
- Guixue Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
- Publication number 20050014786
- Publication date Jan 20, 2005
- Chongqing Sun
- C07 - ORGANIC CHEMISTRY

Doree Sitkoff

Person

Patents Grantslast 30 patents

Fibronectin based scaffold domain proteins that bind PCSK9

Fibronectin based scaffold domain proteins that bind PCSK9

Cyclic ureas as inhibitors of rock

Tied-back benzamide derivatives as potent rock inhibitors

Lactams as inhibitors of rock

Fibronectin based scaffold domain proteins that bind PCSK9

Fibronectin based scaffold domain proteins that bind PCSK9

Fibronectin based scaffold domain proteins that bind to PCSK9

Tetrahydroquinoline derivatives as cannabinoid receptor modulators

Tetrahydroquinoline derivatives as cannabinoid receptor modulators

Bicyclic heterocycles as cannabinoid-1 receptor modulators

Bicyclic heterocycles as cannabinoid-1 receptor modulators

Azabicyclic heterocycles as cannabinoid receptor modulators

Bicyclic heterocycles as cannabinoind-1 receptor modulators

Patents Applicationslast 30 patents

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND PCSK9

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND PCSK9

LACTAMS AS INHIBITORS OF ROCK

CYCLIC UREAS AS INHIBITORS OF ROCK

TIED-BACK BENZAMIDE DERIVATIVES AS POTENT ROCK INHIBITORS

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND PCSK9

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND PCSK9

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO PCSK9

TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS

BICYCLIC HETEROCYCLES AS CANNABINOID-1 RECEPTOR MODULATORS

TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS

Bicyclic heterocycles as cannabinoind-1 receptor modulators

Bicyclic heterocycles as cannabinoid-1 receptor modulators

Azabicyclic heterocycles as cannabinoid receptor modulators

Tetrahydroquinoline derivatives as cannabinoid receptor modulators